Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.71 CAD | -0.52% | -3.38% | -0.87% |
03-11 | National Bank Revises 2024, 2025 Estimates for Dexterra Group Following Q4 Results | MT |
03-11 | Dexterra Upgraded to Outperform at Raymond James | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.87% | 269M | |
+6.67% | 67.85B | |
+14.34% | 50.88B | |
+11.28% | 15.82B | |
+16.42% | 15.4B | |
+19.80% | 10.79B | |
+24.01% | 9.39B | |
+11.86% | 5.13B | |
+4.94% | 4.52B | |
+19.66% | 3.64B |
- Stock Market
- Equities
- DXT Stock
- News Dexterra Group Inc.
- Dexterra Group Brief: Target Upped To C$9.50 From $9 and Outperform Rating Unchanged at National Bank As Q3 Adds "Fuel to the Fire; National Notes WAFES to "Normalize Following Outlier Quarter"